Dangerous herbals, eh?
This article was originally published in The Tan Sheet
Executive Summary
Health Canada issues Type I health warning on Bao Ji Wan Pills and Chinese Modular Solutions Chest Relief because they contain ingredients "considered highly toxic and pose a serious health hazard, particularly to children." While noting no adverse events have been reported, Feb. 28 alert stresses products, containing Tricosanthes kirilowii (associated with cell mutations, malformed embryos, immune suppression and allergic reactions) and Magnolia officinalis (linked to respiratory paralysis in animals and possible pediatric toxicity), respectively, have not been approved for sale in Canada
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning